Financials Camlin Fine Sciences Limited

Equities

CAMLINFINE

INE052I01032

Specialty Chemicals

Market Closed - Bombay S.E. 06:10:16 2024-05-13 am EDT 5-day change 1st Jan Change
98.6 INR -2.13% Intraday chart for Camlin Fine Sciences Limited -4.92% -27.42%

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 6,045 4,777 17,824 21,899 20,006 16,512 - -
Enterprise Value (EV) 1 6,045 4,777 17,824 21,899 20,006 16,512 16,512 16,512
P/E ratio 997 x 15.8 x 38 x 30.6 x 37.3 x -164 x 15.7 x 11.3 x
Yield - - - - - - - -
Capitalization / Revenue 0.68 x 0.46 x 1.5 x 1.55 x 1.19 x 1 x 0.76 x 0.69 x
EV / Revenue 0.68 x 0.46 x 1.5 x 1.55 x 1.19 x 1 x 0.76 x 0.69 x
EV / EBITDA 8.81 x 3.66 x 9.8 x 14.3 x 9.75 x 10.9 x 5.79 x 4.75 x
EV / FCF -7.71 x - 53.2 x -32 x -21.4 x -1.3 x 36 x 11.4 x
FCF Yield -13% - 1.88% -3.12% -4.67% -76.8% 2.78% 8.75%
Price to Book 1.63 x 1.19 x - - 2.44 x 1.67 x 1.51 x 1.33 x
Nbr of stocks (in thousands) 121,254 121,254 127,498 156,984 157,093 167,465 - -
Reference price 2 49.85 39.40 139.8 139.5 127.4 98.60 98.60 98.60
Announcement Date 5/24/19 6/19/20 5/28/21 5/19/22 5/22/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 8,922 10,491 11,871 14,121 16,816 16,471 21,786 23,965
EBITDA 1 686.1 1,307 1,819 1,528 2,053 1,515 2,854 3,475
EBIT 1 396.1 - 1,376 968.4 1,428 719 1,985 2,546
Operating Margin 4.44% - 11.59% 6.86% 8.49% 4.37% 9.11% 10.62%
Earnings before Tax (EBT) 1 166.9 582 1,051 941.1 803.8 9 1,405 1,947
Net income 1 5.772 303.2 509.6 606.8 521.1 -95 984 1,363
Net margin 0.06% 2.89% 4.29% 4.3% 3.1% -0.58% 4.52% 5.69%
EPS 2 0.0500 2.500 3.680 4.560 3.410 -0.6000 6.300 8.700
Free Cash Flow 1 -783.5 - 335.1 -683.4 -934.1 -12,680 459 1,445
FCF margin -8.78% - 2.82% -4.84% -5.55% -76.98% 2.11% 6.03%
FCF Conversion (EBITDA) - - 18.42% - - - 16.08% 41.58%
FCF Conversion (Net income) - - 65.75% - - - 46.65% 106.02%
Dividend per Share - - - - - - - -
Announcement Date 5/24/19 6/19/20 5/28/21 5/19/22 5/22/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 3,838 4,832 3,878 4,267 4,196 4,043 4,120 -
EBITDA 1 466.2 552.1 497.6 438.2 387.1 460 346 425
EBIT - - - - - - - -
Operating Margin - - - - - - - -
Earnings before Tax (EBT) - - 317.9 84.28 - - - -
Net income 58.86 130.2 240.4 91.6 - - - -
Net margin 1.53% 2.69% 6.2% 2.15% - - - -
EPS 0.3700 0.8200 1.510 0.5800 - - - -
Dividend per Share - - - - - - - -
Announcement Date 8/12/22 11/12/22 2/13/23 5/22/23 8/11/23 - - -
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -783 - 335 -683 -934 -12,680 459 1,445
ROE (net income / shareholders' equity) 0.16% 7.83% 9.74% 8.72% 6.65% -1.1% 9.6% 11.7%
ROA (Net income/ Total Assets) - - - - 2.7% -0.5% 4.5% 5.6%
Assets 1 - - - - 19,301 19,000 21,867 24,339
Book Value Per Share 2 30.60 33.20 - - 52.20 59.00 65.30 74.00
Cash Flow per Share 2 - - - - 3.000 5.900 6.200 11.80
Capex 1 694 - 395 2,138 1,443 931 965 878
Capex / Sales 7.77% - 3.33% 15.14% 8.58% 5.65% 4.43% 3.66%
Announcement Date 5/24/19 6/19/20 5/28/21 5/19/22 5/22/23 - - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
98.6 INR
Average target price
150 INR
Spread / Average Target
+52.13%
Consensus
  1. Stock Market
  2. Equities
  3. CAMLINFINE Stock
  4. Financials Camlin Fine Sciences Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW